AC Immune Ratios (2015-2026) | ACIU

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
EBT Margin (Quarter)						-346.46%							-3,312.95%	21.59%	-1,389.09%	-1,922.12%	-1,622.43%	-1,688.82%	-4,252.37%	-1,322.70%
EBIT Margin (Quarter)						-345.21%							-3,051.09%	28.52%	-1,637.47%	-1,956.57%	-1,484.53%	-1,721.62%	-4,258.58%	-1,321.54%
EBITDA Margin (Quarter)						-345.21%							-3,051.09%	28.52%	-1,637.47%	-1,956.57%	-1,484.53%	-1,721.62%	-4,258.58%	-1,321.54%
Operating Margin (Quarter)						-345.21%							-3,051.09%	28.52%	-1,637.47%	-1,956.57%	-1,484.53%	-1,721.62%	-4,258.58%	-1,321.54%
Net Margin (Quarter)						-346.36%							-3,312.95%	21.59%	-1,389.09%	-1,922.12%	-1,622.43%	-1,688.82%	-4,252.37%	-1,322.70%
FCF Margin (Quarter)						-344.00%							10,639.74%	-54.83%	529.82%	-1,918.79%	-1,212.02%	-1,983.17%	-4,918.05%
Efficiency
Assets Average (Quarter)	0.00B	0.00B	0.14B	0.27B	0.24B	0.22B	0.20B	0.19B	0.18B	0.17B	0.18B	0.20B	0.23B	0.27B	0.27B	0.25B	0.23B	0.22B	0.20B
Equity Average (Quarter)	218.49B	201.39B	97.72B	0.24B	0.22B	0.20B	0.19B	0.17B	0.16B	0.15B	0.16B	0.17B	0.15B	0.14B	0.14B	0.12B	0.10B	0.08B	0.07B
Invested Capital (Quarter)	207.58B	195.19B	0.28B	0.23B	0.21B	0.20B	0.19B	0.17B	0.15B	0.14B	0.20B	0.17B	0.14B	0.15B	0.15B	0.11B	0.09B	0.08B	0.07B
Asset Utilization Ratio (Quarter)						0.03							0.03	0.13	0.13	0.13	0.14	0.02	0.02
Leverage & Solvency
Interest Coverage Ratio (Quarter)	92.52	112.06	131.72	122.27	157.61	174.84	26.56	-181.14	631.33	594.85	10.83	557.44	616.50	-220.27	-79.56	358.70	387.76	351.43	342.71	227.51
Debt to Equity (Quarter)
Debt Ratio (Quarter)
Equity Ratio (Quarter)	0.00B	0.00B	0.89	0.91	0.94	0.92	0.91	0.90	0.89	0.88	0.88	0.86	0.52	0.53	0.49	0.45	0.39	0.36	0.29
Times Interest Earned (Quarter)	92.52	112.06	131.72	122.27	157.61	174.84	26.56	-181.14	631.33	594.85	10.83	557.44	616.50	-220.27	-79.56	358.70	387.76	351.43	342.71	227.51
Valuation
Enterprise Value (Quarter)	0.03B	0.03B	-125.89B	-0.19B	-0.11B	-0.07B	-0.13B	-0.11B	-0.08B	-0.08B	-0.16B	-0.12B	-0.22B	-0.18B	0.08B	-0.16B	-0.17B	-0.14B	-0.11B
Return Ratios
Return on Sales (Quarter)						-0.03%							-0.33%	0.00%	-0.14%	-0.19%	-0.16%	-0.17%	-0.43%	-0.13%
Return on Capital Employed (Quarter)	0.63%	0.54%	0.40%	-34.20%	-38.57%	-38.88%	-38.93%	-41.38%	-42.98%	-48.44%	0.39%	-34.73%	-58.34%	-26.82%	-37.45%	-41.49%	-51.30%	-87.05%	-97.53%
Return on Invested Capital (Quarter)				0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.01%	0.00%
Return on Assets (Quarter)	-3.38%	-3.46%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.01%	-0.01%	-0.01%

Research Tools

AC Immune Ratios (2015-2026) | ACIU

Create an account

Sign In

Reset Password